Insight

Sergio Cifuentes: The Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer

Photo taken from Sergio Cifuentes Canabal/LinkedIn

Sep 24, 2024, 14:18

Sergio Cifuentes: The Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer

Sergio Cifuentes, Cancer Research Project Manager at CENEIT Mexico, shared on X:

“Check out my latest Insights – Characterizing the Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer.

Characterizing the Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer

Prevalence: KRAS is the most common oncogene alteration in pancreatic ductal adenocarcinoma, and KRAS G12Cmut found in 1%-2% of pancreatic ductal adenocarcinoma cases.

Key Findings

The median age of the patients was 67, with 56% being female and a median BMI of 29.2 kg/m2. Sixty-seven percent had smoked at some point in their lives.
Survival Rates: Median overall survival was 13 months for stage IV and 26 months for stage I-III.
Commonly co-altered genes: TP53 (73%), CDKN2A (33%), SMAD4 (28%), and ARID1A (21%).
Overall survival did not differ between KRAS G12Cmut and non-G12C KRAS pancreatic ductal adenocarcinoma.

Clinical Implications

Distinct Phenotype: KRAS G12Cmut linked to unique clinical characteristics in pancreatic cancer.
Genomic Similarities: Resemblance to non-G12C KRAS mutations, highlighting the significance of ARID1A co-mutations.
Treatment Potential: Targeting KRAS G12C sets the stage for broader KRAS-focused therapies in pancreatic cancer.”

Sergio Cifuentes

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

Authors: Fergus Keane, Joanne F Chou, Henry Walch, Joshua Schoenfeld, Anupriya Singhal, Darren Cowzer, Emily Harrold, Catherine A O’Connor, Wungki Park, Anna Varghese, Imane El Dika, Fiyinfolu Balogun, Kenneth H Yu, Marinela Capanu, Nikolaus Schultz, Rona Yaeger, Eileen M O’Reilly,

Sergio Cifuentes

Source: Sergio Cifuentes/X

Anna Varghese Anupriya Singhal cancer Catherine A. O’Connor Darren Cowzer Eileen M. O'Reilly Emily Harrold Fergus Keane Fiyinfolu Balogun Henry Walch Imane El Dika Joanne F. Chou Joshua Schoenfeld Kenneth H Yu KRAS G12C–Mutated Pancreatic Cancer Marinela Capanu Nikolaus Schultz OncoDaily Oncology Pancreatic Cancer Rona Yaeger Sergio Cifuentes Wungki Park

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage